BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. — Investor Relations & Filings
Beijing Leadman Biochemistry Co., Ltd. specializes in the research, development, manufacturing, and distribution of in-vitro diagnostic (IVD) solutions. The company’s core portfolio includes a wide range of clinical chemistry reagents, chemiluminescence immunoassay kits, and automated diagnostic instruments. These products support various medical testing areas, such as liver and kidney function, lipid profiles, and cardiac markers. By providing integrated systems that combine high-performance reagents with specialized hardware, the company serves hospitals, clinical laboratories, and medical institutions. Its operations focus on delivering precise and efficient diagnostic tools to enhance clinical decision-making and patient care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2025年度股东会的通知 | 2026-03-30 | Chinese | |
| 2025年度非经营性资金占用及其他关联资金往来情况的专项审核说明 | 2026-03-30 | Chinese | |
| 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-30 | Chinese | |
| 2025年度董事会工作报告 | 2026-03-30 | Chinese | |
| 营业收入扣除情况的专项核查意见 | 2026-03-30 | Chinese | |
| 2025年度会计师事务所履职情况评估报告 | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36620283 | 关于召开2025年度股东会的通知 | 2026-03-30 | Chinese | ||
| 36620273 | 2025年度非经营性资金占用及其他关联资金往来情况的专项审核说明 | 2026-03-30 | Chinese | ||
| 36620196 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-03-30 | Chinese | ||
| 36620195 | 2025年度董事会工作报告 | 2026-03-30 | Chinese | ||
| 36620192 | 营业收入扣除情况的专项核查意见 | 2026-03-30 | Chinese | ||
| 36620189 | 2025年度会计师事务所履职情况评估报告 | 2026-03-30 | Chinese | ||
| 36620186 | 2025年度独立董事述职报告（张志谦） | 2026-03-30 | Chinese | ||
| 36620171 | 关于2025年度计提资产减值准备及冲回信用减值损失的公告 | 2026-03-30 | Chinese | ||
| 36620165 | 第六届董事会第九次会议决议公告 | 2026-03-30 | Chinese | ||
| 36620164 | 董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告 | 2026-03-30 | Chinese | ||
| 36620154 | 2025年度财务决算报告 | 2026-03-30 | Chinese | ||
| 36620152 | 关于2025年度拟不进行利润分配的公告 | 2026-03-30 | Chinese | ||
| 36620148 | 董事会关于独立董事独立性情况的专项意见 | 2026-03-30 | Chinese | ||
| 36620147 | 2025年年度审计报告 | 2026-03-30 | Chinese | ||
| 36620144 | 2025年年度报告 | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55291/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55291 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55291 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55291 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55291}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. (id: 55291)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.